About us Contacts Interactions: 118 620
Drug search by name

Sandostatin LAR Depot injection and Renal dysfunction

Result of checking the interaction of drug Sandostatin LAR Depot injection and disease Renal dysfunction for safety when used together.

Check result:
Sandostatin LAR Depot injection <> Renal dysfunction
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Octreotide is eliminated by the kidney. Approximately 30% of octreotide is excreted unchanged in the urine. The serum concentration of octreotide and the half-life is increased in patients with severe renal dysfunction. Therapy with octreotide should be administered cautiously and dosage modification considered in patients with severe renal impairment as the half-life of octreotide may be increased, necessitating adjustment of the dosage.

References:
  • "Product Information. Sandostatin (octreotide)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
Sandostatin LAR Depot injection

Generic Name: octreotide

Brand Name: Sandostatin, Sandostatin LAR Depot

Synonyms: Sandostatin LAR Depot (injection)

Interaction with food and lifestyle